Prestwick3_001030

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

45 API Suppliers, 21 USDMF, 19 CEP/COS, 1 JDMF, 9 EU WC, 3 KDMF, 13 NDC API, 28 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

12 API Suppliers

12 API Suppliers

FINISHED DOSAGE FORMULATIONS

213 FDF Dossiers, 48 FDA Orange Book, 122 Europe, 5 Canada, 14 South Africa, 24 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 1 DKSH, 8 Boai NKY Pharmaceuticals Ltd, 12 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 14 BASF, 1 BioSpectra, 1 Clariant, 6 DFE Pharma, 6 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 25 Kerry, 12 Microlex e.U, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 15 Roquette, 1 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 10 Sigachi Industries, 3 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

69 Fillers, Diluents & Binders, 37 Direct Compression, 31 Disintegrants & Superdisintegrants, 20 Granulation, 18 Co-Processed Excipients, 17 Thickeners and Stabilizers, 13 Lubricants & Glidants, 10 Solubilizers, 8 Controlled & Modified Release, 8 Chewable & Orodispersible Aids, 6 Parenteral, 5 Taste Masking, 5 Coating Systems & Additives, 3 Film Formers & Plasticizers, 3 Topical, 3 Emulsifying Agents, 2 API Stability Enhancers, 2 Rheology Modifiers, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 5 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 103 Finished Drug Prices

MARKET PLACE

12 APIs, 12 FDF Dossiers, 1 Intermediates

PATENTS & EXCLUSIVITIES

2 US Patents, 5 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 5 USP, 14 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 20136 / DOSAGE - TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
TORSEMIDE(UNII: W31X2H97FB) (TORSEMIDE - UNII:W31X2H97FB)	TORSEMIDE	20mg \| 10mg \| 100mg

Drug Product Composition: Prestwick3_001030